Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Smith-Byrne, Karl et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224462

Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: PSA is central to referrals for prostate biopsy but has low specificity for aggressive prostate cancer. This study evaluates the 4Kscore (OPKO Diagnostics) versus total PSA in predicting short- and long-term risks of aggressive prostate cancer. Methods: Baseline blood samples from 1,658 men diagnosed with prostate cancer (median diagnosis time = 8.6 years) and 1,658 matched controls in the European Prospective Investigation into Cancer and Nutrition were analyzed. Discrimination for the 4Kscore and total PSA was assessed using the AUC with 95% confidence intervals (CI) via bootstrapping. Results: For high-grade tumors, AUCs were 0.69 (95% CI, 0.66-0.72) for the 4Kscore and 0.75 (95% CI, 0.73-0.78) for total PSA. For advanced-stage disease, AUCs were 0.71 (95% CI, 0.66-0.75) for the 4Kscore and 0.77 (95% CI, 0.73-0.80) for total PSA. Similar findings were observed for other aggressive cancer endpoints. Among men with PSA >2 ng/mL, the 4Kscore had better discrimination than PSA for overall prostate cancer, high-grade disease, and prostate cancer death but only in men <60 years at recruitment. Conclusions: In this large European study, the 4Kscore did not significantly improve the prediction of clinically significant prostate cancer compared with total PSA, except in younger men with elevated PSA. Impact: The findings underscore the limited utility of the 4Kscore in improving medium- to longer-term risk prediction over PSA, with potential benefits restricted to younger men with elevated PSA.

Citació

Citació

SMITH-BYRNE, Karl, FENSOM, Georgina k., NOOR, Urwah, WATTS, Eleanor l., ALLEN, Naomi e., AMIANO, Pilar, CHIRLAQUE, María dolores, CROUS BOU, Marta, GUEVARA ESLAVA, Marcela, PALLI, Domenico, KATZKE, Verena, SACERDOTE, Carlotta, SÁNCHEZ PÉREZ, María josé, SCHULZE, Matthias b., SIERI, Sabina, TUMINO, Rosario, TSILIDIS, Konstantinos k., KAAKS, Rudolf, GUNTER, Marc j., RIBOLI, Elio, KEY, Timothy j., TRAVIS, Ruth c.. Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition. _Cancer Epidemiology Biomarkers & Prevention_. 2025. Vol. 34, núm. 11, pàgs. 2058-2067. [consulta: 22 de gener de 2026]. ISSN: 1538-7755. [Disponible a: https://hdl.handle.net/2445/224462]

Exportar metadades

JSON - METS

Compartir registre